Funding opportunities

MedTech Grant Funding Opportunities

To apply for any of the MedTech grant funding opportunities listed below, please do get in touch for more information.

SBRI: Mental Health Inequalities in Children and Young People

Deadline: Wednesday 13th October 2021

Funding: £500,000

SBRI Healthcare, funded by NHS England and NHS Improvement and in collaboration with the AHSN Network is pleased to announce the launch of a new competition on Mental Health Inequalities in Children and Young People with focus on the two main following challenges:

  • Mental health services/support improvements
  • Equity of mental health access for disadvantaged, marginalised or BAME Communities

NIHR Artificial intelligence for Multiple Long-Term Conditions

Deadline: Tuesday 5th October 2021

Funding: £4,000,000

Wave 2 is opened for Development Award holders only funded by Wave 1. However, the wave 2 competition will not be open to new Research Collaboration applications. The AIM call will fund programmes of research which will use AI and data science methods, combined with expertise in clinical practice, applied health and care research and social science, to systematically identify or explore clusters of disease. In addition to the identification and mapping of new clusters of disease, the call seeks research to better understand the trajectories of patients with MLTC-M over time and throughout the life course, including the influence of wider determinants such as environmental, behavioral and psychosocial factors.

NIHR: Artificial Intelligence in Health and Care Award (AI Award)

Deadline: Tuesday 7th September

Funding: Discretionary

Phase 2 of the award supports the development and clinical evaluation of AI technologies. Phases 3 and 4 of the award support real world testing, initial systems adoption of AI technologies into the NHS, evaluating the AI technology within clinical or operational pathways to determine efficacy or accuracy and clinical and economic impact.

NIHR: Health Technology Assessment

Closing Date: None Specified

Funding: Discretionary

The Health Technology Assessment (HTA) Programme funds research about the clinical and cost-effectiveness and broader impact of healthcare treatments and tests for those who plan, provide or receive care from NHS and social care services. They have a number of themed calls, please refer their website for more information.

NIHR: Efficacy and Mechanism Evaluation Programme

Closing Date: None Specified

Funding: Discretionary

The EME Programme primarily supports clinical trials, and other robustly designed studies that test the efficacy of interventions. The interventions should have the potential to improve patient care or benefit the public. The programme will only support studies where there is sufficient evidence that the intervention might work in man, i.e. that there is ‘proof of concept’. Current calls here include Cystic Fibrosis, Novel strategies to reduce overtreatment, Paediatric Care among others.

i4i Connect

Deadline: 14 September 2021

Funding: £150,00

i4i Connect is aimed at small-to-medium-sized enterprises (SMEs) in need of a funding boost to reach the next stage in the development pathway. Eligible SMEs may comprise developers of medical devices, in vitro diagnostics and digital health technologies with direct patient benefits, looking to ultimately integrate into the NHS. The funding stream aims to help SMEs get to a point where they can apply for further funding, in particular for an i4i Product Development Award. It also aims to de-risk projects at any stage of the translational research and development pathway to support follow-on investment.

i4i Product Development Awards

Deadline: 8 December 2021

Funding: Discretionary

i4i Product Development Awards (PDA) support innovations at any stage of the translational research and development pathway, including the clinical development of laboratory-validated technologies or interventions. This funding stream is researcher-led and does not specify topics for research. Research proposals must include applicants from two organisation types: an NHS Trust, higher education institution or small-to-medium-sized enterprise (SME).

Unified Tech Fund: Digital Productivity

Deadline: 30 November 2021

Available funding: £4 million

The Unified Tech Fund (UTF), part of the Who Pays for What strategy, seeks to simplify and consolidate the process for accessing technology funding. Eligible applicants include NHS organisations, social care organisations and local government, CCGs, ICSs, voluntary, community and social enterprise alliances.

Support is available to accelerate the adoption and utilisation of proven productivity-improving digital technologies such as:

  • Real time location services including radio frequency identification devices
  • Robotic process automation
  • Virtual and augmented reality technologies
  • Intelligent automation
  • Value added labour saving digital capabilities across all system

Horizon 2020 funding

Horizon 2020 is the largest ever European funding programme for research and innovation. It has a budget of 79 billion euros and will run throughout 2020.Horizon 2020 aims to ensure that Europe produces world-class science remove barriers to innovation make it easier for public and private sectors to innovate together UK scientists, researchers and businesses can continue to participate in Horizon 2020 programmes and receive EU grant funding for the lifetime of individual projects, This includes projects finishing after 1 January 2021.

Nesta Impact Investment

Deadline: None Specified

Funding: £1,000,000

Nesta Impact Investments is a £17.6m fund investing in life changing innovations that help tackle the major challenges faced by older people, children and communities in the UK.

Global Innovation Fund

Deadline: None Specified

Funding: Discretionary

The Global Innovation Fund is a non profit innovation fund headquartered in London with an office in Washington D.C. that invests in the development, rigorous testing, and scaling of innovations targeted at improving the lives of the world's poorest people. Through our grants and risk capital, we help breakthrough solutions to global development challenges from for profit firms, non profit organisations, researchers, and government agencies to maximise their impact and affect meaningful change.

Asthma Health Technology Fund

Deadline: None Specified

Funding: Discretionary

NIHR, EPSRC and Asthma UK and the British Lung Foundation have come
together to launch a multi million pound fund to support the development and adoption of asthma health technologies. This fund has been designed to support innovation from concept stage through to scaling in the NHS. The purpose of this call is to support the research and development of novel solutions to prevent asthma attacks and improve the lives of people with asthma. The areas of focus should fall into any of the following areas: Diagnosis, Self management, Treatment optimization, Monitoring, Risk stratification.

IndieBio Coronavirus Initiative

Deadline: None Specified

Funding: Discretionary

We are seeking up to 8 startups to receive a minimum of $250,000 each to pursue the development of diagnostics, therapeutics, vaccines, disinfection, and other solutions addressing the worldwide problem of emerging infectious diseases. Companies who focus on detection may include those that:

• Improve diagnostic capabilities in speed, cost, or scaling.
• Predict negative post-infection sequelae for COVID-19 patients.
• Enhance serological testing kits.

Other Support Available


Rolling call for applications

The MedTech NAVIGATOR programme, delivered by Health Enterprise, provides Innovation Grants to SMEs to engage in new research and innovation activities with eligible knowledge providers. Businesses can apply for funding to access expert advice, product review by stakeholders or to carry out early stage proof of concept activities.

Keep up to date with all HEE news and events.

We take your data very seriously, please read our privacy policy.

Talk to us

We offer a free 30-minute consultation to explore how our team of experts can help you develop, commercialise and scale your medical technology.

Book Now